LONDON, Sept. 15, 2021 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (the “ Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to announce it has engaged Kanan Corbin Schupak & Aronow, Inc. d/b/a KCSA Strategic Communications (“KCSA”) to provide investor relations and public relations services (the “Services”). KCSA has agreed to…


Previous articleFear of Death Impacts Quality of Life-How Psychedelics Can Help
Next articleUnderstanding ‘Spiritual Emergency’ in the Context of Psychedelics